Search - tctmd.com

Displaying 1 - 20 of 60

Sort: Relevancy | Date

Presentation TCT 2025

Mitigating Stroke Risk in TAVR: Role of SENTINEL Embolic Protection

Presenter: Alexandra J. Lansky

October 28, 2025

Presentation TCT 2025

Clinical Path SERRA-I Early Feasibility Study

Presenter: Alexandra J. Lansky

October 26, 2025

Presentation TCT 2024

Variations in New Clinical Trial Designs for Emerging CEP Devices

Presenter: Alexandra Lansky

October 30, 2024

Presentation TCT 2024

Academic Promotions – How Do you Do it Successfully

Presenter: Alexandra Lansky

October 29, 2024

Presentation TCT 2024

Interpreting the PEERLESS Trial Through the Statistical Lens

Presenter: Alexandra Lansky

October 29, 2024

Presentation TCT 2024

Importance of DW-MRI in Cerebral Embolic Protection Trials

Presenter: Alexandra Lansky

October 28, 2024

Presentation TCT 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presenter: Alexandra Lansky

October 27, 2024

Presentation TCT 2023

Beyond Support: Impella® as a Risk Modifier

Presenter: Alexandra Lansky

October 24, 2023

News Conference News TCT 2022

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

Yael L. Maxwell

September 18, 2022

Presentation TCT 2022

For Most Patients, Only Spontaneous MI Is Relevant

Presenter: Alexandra J. Lansky

September 18, 2022

Presentation TCT 2022

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Presenter: Alexandra Lansky

September 18, 2022

Presentation TCT 2022

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

Presenter: Alexandra J. Lansky

September 17, 2022

Presentation TCT 2021

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

Presenter: Alexandra Lansky

November 06, 2021

Presentation TCT 2021

Disrupt CAD Pooled Female vs Male Analysis

Presenter: Alexandra Lansky

November 05, 2021

Presentation TCT 2020

TCT 181: A Propensity Matched Analysis of Impella use From a Large-Scale Claims Data: Influence of Analytic Methodology on Clinical Outcomes

Presenter: Alexandra Lansky

October 14, 2020

Presentation TCT 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Alexandra J. Lansky, Axel Linke, Tamim Nazif

September 22, 2018

Presentation TCT 2018

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

Presenter: Alexandra J. Lansky, Axel Linke, Samir R. Kapadia

September 22, 2018

Presentation TCT 2018

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

Presenter: Alex Chebl, Alexandra J. Lansky, Liang Tang

September 21, 2018

Presentation TCT 2018

TCT-71: Predictors, Incidence and Outcomes of Patients Undergoing Transcatheter Aortic Valve Implantation Complicated by Stroke From the CENTER-Collaboration

Presenter: Alex Chebl, Alexandra J. Lansky, Wieneke Vlastra

September 21, 2018

Presentation TCT 2018

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

Presenter: Alex Chebl, Alexandra J. Lansky, Chetan Huded

September 21, 2018

Advertisement

Mitigating Stroke Risk in TAVR: Role of SENTINEL Embolic Protection

Clinical Path SERRA-I Early Feasibility Study

Variations in New Clinical Trial Designs for Emerging CEP Devices

Academic Promotions – How Do you Do it Successfully

Interpreting the PEERLESS Trial Through the Statistical Lens

Importance of DW-MRI in Cerebral Embolic Protection Trials

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Beyond Support: Impella® as a Risk Modifier

Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI

For Most Patients, Only Spontaneous MI Is Relevant

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Regulatory Pathways and Clinical Trials After PROTECTED TAVR

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

Disrupt CAD Pooled Female vs Male Analysis

TCT 181: A Propensity Matched Analysis of Impella use From a Large-Scale Claims Data: Influence of Analytic Methodology on Clinical Outcomes

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

A Stroke after TAVR Primer: Time Course, Changing Incidence, Ascertainment Challenges, and Comparison vs. Surgery

TCT-72: A Prospective Evaluation for Hypoattenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement

TCT-71: Predictors, Incidence and Outcomes of Patients Undergoing Transcatheter Aortic Valve Implantation Complicated by Stroke From the CENTER-Collaboration

TCT-70: Incidence, Trends, and Risk Factors for Early Stroke after Transcatheter Aortic Valve Replacement in the First 5 years of US Clinical Practice: Report of the STS/ACC TVT Registry.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content